CLINICAL_TRIALS
trial_result
· 2020-07-16
Clinical Trial Update: Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 safety study of PLX3397 with Paclitaxel in patients with advanced solid tumors completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2020-07-16